As part of a makeover promised last year, Bayer is beginning a process of staff reductions that aims to slice through the bureaucracy CEO Bill Anderson blames for the company’s sluggish performance.
https://www.biopharmadive.com/news/bayer-restructuring-layoffs-germany-labor-bill-anderson/704872/